2019 annual financial data
Heron Therapeutics 2019 Operating margin
Direct answer
Operating margin was -144.34%.
Operating income was -210,694,000 USD and net income was -204,749,000 USD.
Operating cash flow was -124,580,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 145,968,000 USD
- Operating income
- -210,694,000 USD
- Net income
- -204,749,000 USD
- Operating cash flow
- -124,580,000 USD